Details of the Drug Reposition

General Information of This Drug (ID: DM3WCL4)

• Drug Name: Baltaleucel-T (DM3WCL4)

Information on Drug Reposition of This Drug

4 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Lymphoma	DISN6V4S	2A80-2A86	Phase 2	[1]
Diffuse large B-cell lymphoma	DISSACK3	2A81	Phase 2	[1]
Hodgkin lymphoma	DISX2OUL	2B30	Phase 2	[1]
Post-transplant lymphoproliferative disorder	DISTS43D	2B32	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)